tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PRTA Stock Latest News

Prothena price target lowered to $11 from $29 at Citizens JMP
The FlyProthena price target lowered to $11 from $29 at Citizens JMP
16d ago
PRTA
Prothena price target lowered to $15 from $81 at Piper Sandler
PremiumThe Fly
Prothena price target lowered to $15 from $81 at Piper Sandler
21d ago
PRTA
Prothena Announces Promising Phase 1 Results for PRX012
PremiumCompany Announcements
Prothena Announces Promising Phase 1 Results for PRX012
22d ago
8K
PRTA
Prothena announces Novo Nordisk to advance coramitug into Phase 3
PremiumThe Fly
Prothena announces Novo Nordisk to advance coramitug into Phase 3
1M ago
NVO
PRTA
Prothena’s Coramitug Advances to Phase 3 with Novo Nordisk
PremiumCompany Announcements
Prothena’s Coramitug Advances to Phase 3 with Novo Nordisk
1M ago
8K
PRTA
Prothena’s Strategic Initiatives and Promising Alzheimer’s Pipeline Drive Buy Rating
PremiumRatingsProthena’s Strategic Initiatives and Promising Alzheimer’s Pipeline Drive Buy Rating
1M ago
PRTA
Prothena Reports Q2 2025 Financial Results and Pipeline Progress
Premium
Company Announcements
Prothena Reports Q2 2025 Financial Results and Pipeline Progress
1M ago
PRTA
Prothena reports Q2 EPS ($2.34), consensus ($1.79)
Premium
The Fly
Prothena reports Q2 EPS ($2.34), consensus ($1.79)
2M ago
PRTA
PRTA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
PRTA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
PRTA
Prothena Secures Leadership with New Executive Agreements
PremiumCompany Announcements
Prothena Secures Leadership with New Executive Agreements
2M ago
8K
PRTA
Closing Bell Movers: GMS up 15% on takeover proposal from QXO
PremiumThe Fly
Closing Bell Movers: GMS up 15% on takeover proposal from QXO
3M ago
APG
GMS
Prothena Announces Major Workforce Reduction to Cut Costs
PremiumCompany Announcements
Prothena Announces Major Workforce Reduction to Cut Costs
3M ago
8K
PRTA
Prothena up 3% after announcing corporate restructuring, cash burn update
PremiumThe FlyProthena up 3% after announcing corporate restructuring, cash burn update
3M ago
PRTA
Prothena sees 2025 net cash burn from operating/investing at $170M-$178M
Premium
The Fly
Prothena sees 2025 net cash burn from operating/investing at $170M-$178M
3M ago
PRTA
Prothena Chief Regulatory Officer Karp, Chief People Officer Ford to depart
Premium
The Fly
Prothena Chief Regulatory Officer Karp, Chief People Officer Ford to depart
3M ago
PRTA
Prothena announces corporate restructuring, cuts 63% of workforce
PremiumThe Fly
Prothena announces corporate restructuring, cuts 63% of workforce
3M ago
BMY
NVO
Morning Movers: Sage Therapeutics surges after deal to be acquired by Supernus
PremiumThe Fly
Morning Movers: Sage Therapeutics surges after deal to be acquired by Supernus
3M ago
X
AMZN
Prothena partner Roche advances prasinezumab into Phase 3
PremiumThe Fly
Prothena partner Roche advances prasinezumab into Phase 3
3M ago
CHRO
PRTA
Prothena’s Prasinezumab Advances to Phase III for Parkinson’s
PremiumCompany Announcements
Prothena’s Prasinezumab Advances to Phase III for Parkinson’s
3M ago
8K
PRTA
Altria, Prime Medicine, US Steel, DLocal, Prothena: Trending by Analysts
PremiumWeekend UpdatesAltria, Prime Medicine, US Steel, DLocal, Prothena: Trending by Analysts
4M ago
X
MO
Buy/Sell: Wall Street’s top 10 stock calls this week
Premium
The Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
4M ago
X
BAH
Prothena downgraded to Underperform at BofA after birtamimab fails in clinic
Premium
The Fly
Prothena downgraded to Underperform at BofA after birtamimab fails in clinic
4M ago
PRTA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >